Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based biotechnology company Lentigen has relocated its corporate headquarters, research labs and manufacturing from the University of Maryland Baltimore County TechCenter to 910 Clopper Road, Suite 200 South Building, Gaithersburg, Maryland.
Subscribe to our email newsletter
Located along Maryland’s I-270 technology corridor, the almost 26,000sqft facility will accommodate the company’s future growth needs as the developer and manufacturer of lentiviral vectors (LVs) and proteins for a wide range of clinical and research applications, said Lentigen.
Two self-contained suites measuring 4,900sqft will allow the simultaneous production of both LVs and proteins in compliance with FDA-regulated current good manufacturing practices (cGMP), the company added.
Tim Ravenscroft, Lentigen’s CEO, said: “The new facility provides an opportunity to expand our research programs. More importantly, the addition of the cGMP manufacturing suites will allow us to manage our programs from the labs through manufacturing to the clinic.
“We plan to manufacture lentiviral products for clinical trials during 2009 and we will have capacity to handle manufacturing projects for collaborators as the market for lentiviral products expands.”